Maximum total vehicle value including all options.
Final day agencies can place orders under this vehicle.
None
NEW AWARD FOR EMTRICITABINE 200MG/TENOFOVIR DISOPROXIL FUMARATE 300MG TABLETS WITH AVKARE, LLC. BASE YEAR ORDERING PERIOD IS OCTOBER 6, 2025 TO OCTOBER 5, 2026 WITH FOUR ONE-YEAR OPTIONS.
Prime task and delivery orders under this vehicle. Subcontracts excluded.
0
$0
$0
$0
PIID | Awardee | Award Date | Total Contract Value | Description |
|---|---|---|---|---|
Note: Values reflect obligated amounts to date and may change as modifications are posted.
Financial changes posted under this vehicle over time (for example base awards and modifications).
Mod # | Transaction Date | Action Type | Description |
|---|---|---|---|
Loading solicitation context and awardees...
Context for the original solicitation under which this vehicle was awarded, plus all awardees under that solicitation.
This section covers solicitation-level context for this vehicle and all awardees.
3
Total number of bids received for the original solicitation.
0
Total number of vendors awarded vehicles under this solicitation.
Explore the full solicitation record in Opportunities, including documents, contacts, and history.
Open in OpportunitiesThese are the companies that won a place on this vehicle under the original solicitation.
PIID | Awardee | Award Date | Total Contract Value |
|---|---|---|---|
No awardees found We couldn't find awardees for this solicitation. | |||